Prosecuting "Responsible" Execs: FDA Brandishes Powerful Legal Weapon
Executive Summary
Company executives increasingly could be caught on the wrong side of virtually unbeatable government criminal prosecutions if FDA follows up on recently announced enforcement plans, industry attorneys warn
You may also be interested in...
Park Doctrine’s Use Should Hinge On Individual’s Knowledge Of Wrongdoing, Prosecutor Says
Application of the Park doctrine to hold corporate officers strictly liable should depend upon an individual’s knowledge of wrongdoing committed under the Food, Drug and Cosmetic Act, Assistant U.S. Attorney for the District of Massachusetts Sara Bloom tells a compliance conference.
Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First
FDA appears likely to target flagrant off-label promotion in its first cases under new procedures for using the Park Doctrine and strict liability statutes to prosecute corporate executives and others.
Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First
FDA appears likely to target flagrant off-label promotion in its first cases under new procedures for using the Park Doctrine and strict liability statutes to prosecute corporate executives and others.